| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 10/01/2013 | US8545854 Tuberculosis vaccine with improved efficacy |
| 10/01/2013 | US8545842 Polynucleotides encoding IL-17 receptor A antigen binding proteins |
| 10/01/2013 | CA2504694C Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 10/01/2013 | CA2424379C Inhibition of complement c5 activation for the treatment and prevention of delayed xenograft or acute vascular rejection |
| 09/26/2013 | WO2013138937A1 A nucleic acid detection method comprising target specific indexing probes (tsip) comprising a releasable segment to be detected via fluorescence when bound to a capture probe |
| 09/26/2013 | WO2013138930A1 Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo |
| 09/26/2013 | WO2012135620A3 Molecular gram stain |
| 09/26/2013 | US20130254938 Precise breeding-simultaneous silencing |
| 09/26/2013 | US20130254935 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use |
| 09/26/2013 | US20130253179 Functionalization Processes and Reactants Used in Such Processes Using an Isatoic Anhydride or a Derivative Thereof, Biological Molecules Thus Treated and Kits |
| 09/26/2013 | US20130253178 2'-o-modified rna |
| 09/26/2013 | US20130253042 Oligonucleotide Conjugates |
| 09/26/2013 | US20130253034 2'-Arabino-Fluorooligonucleotide N3'-->P5' Phosphoramidates: Their Synthesis and Use |
| 09/26/2013 | US20130252852 Oligonucleotides Related to Lipid Membrane Attachment |
| 09/26/2013 | US20130252850 Alpha-Amylase Variants |
| 09/26/2013 | US20130252842 Methine-Substituted Cyanine Dye Compounds |
| 09/26/2013 | US20130252239 Primers and Methods for the Detection and Discrimination of Nucleic Acids |
| 09/26/2013 | US20130251637 Fluorescent compounds |
| 09/25/2013 | EP2641971A1 Compounds and methods for modulating protein expression |
| 09/25/2013 | EP2640853A2 Modulation of alpha synuclein expression |
| 09/25/2013 | EP2640744A2 Neutralizing anti-ccl20 antibodies |
| 09/25/2013 | EP2640420A2 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response |
| 09/25/2013 | EP2640399A2 Methods and compositions for modulating pd1 |
| 09/25/2013 | CN102066561B Method of synthesizing polynucleotide variants |
| 09/25/2013 | CN102037144B Stabilized nucleic acid dark quencher-fluorophore probes |
| 09/25/2013 | CN101374536B Formulations of human growth hormone comprising a non-naturally encoded amino acid |
| 09/24/2013 | US8541664 Soybean cultivar 15115139 |
| 09/24/2013 | US8541650 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding LNT1 polypeptides and homologs thereof |
| 09/24/2013 | US8541583 Monofunctionalized perylenetetracarboxylic acid bismides |
| 09/24/2013 | US8541569 Phosphoramidites for synthetic RNA in the reverse direction, efficient RNA synthesis and convenient introduction of 3'-end ligands, chromophores and modifications of synthetic RNA |
| 09/24/2013 | US8541568 Compositions and methods using siRNA molecules for treatment of gliomas |
| 09/24/2013 | US8541567 Transition state structure of 5′-methylthioadenosine/s-adenosylhomocysteine nucleosidases |
| 09/24/2013 | US8541565 Polynucleotide encoding anti-CD14 antibody fusion protein |
| 09/24/2013 | US8541564 Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof |
| 09/24/2013 | US8541563 Plant wall degradative compounds and systems |
| 09/24/2013 | US8541562 Bridged artificial nucleoside and nucleotide |
| 09/24/2013 | US8541561 DNA aptamer specifically binding to pLDH (plasmodium lactate dehydrogenase) |
| 09/24/2013 | US8541560 Polypeptides comprising Fas activation and NKG2D-ligand domains |
| 09/24/2013 | US8541559 Process for producing aggregated oligonucleotides |
| 09/24/2013 | US8541558 Fluorescent proteins and uses thereof |
| 09/24/2013 | US8541555 Hydrazone-based and oxime-based fluorescent and chromophoric/pro-fluorescent and pro-chromophoric reagents and linkers |
| 09/24/2013 | US8541550 Methods and compositions for delivering polynucleotides |
| 09/24/2013 | US8541390 Treatment of cancer by inhibition of IGFBPs and clusterin |
| 09/24/2013 | US8541388 Methods for modulating expression of RBP4 |
| 09/24/2013 | US8541387 Modulation of SMRT expression |
| 09/24/2013 | US8541386 Cannabinoid 2 (CB2) receptor gene promoter and unique RNA transcripts in B cells and methods of use |
| 09/24/2013 | US8541384 Gene expression inhibition using small interfering RNAs which are specific for the vascular endothelial growth factor (VEGF) gene and the VEGF receptor genes Flt-1 and Flk-1/KDR; diabetic retinopathy, age related macular degeneration and many types of cancer |
| 09/24/2013 | US8541220 Isomerases, nucleic acids encoding them and methods for making and using them |
| 09/24/2013 | US8541218 High fidelity thermostable ligase and uses thereof |
| 09/24/2013 | US8541215 Microorganisms, selenium acid compound-reducing agent, method for reducing and method for removing selenium acid compound, and process for producing metallic selenium |
| 09/24/2013 | US8541203 Activatable binding polypeptides and methods of identification and use thereof |
| 09/24/2013 | US8541202 Method for inducing cell lysis with immunogenic portions of NY-ESO-1 protein |
| 09/24/2013 | US8541199 Mutant penicillin G acylases |
| 09/24/2013 | US8541191 Hydrolases, nucleic acids encoding them and methods for biocatalytic synthesis of structured lipids |
| 09/24/2013 | US8541173 Endometriosis-related markers and uses thereof |
| 09/24/2013 | US8541171 Assay for detection of human parvovirus B19 nucleic acid |
| 09/24/2013 | CA2692503C Dsrna for treating viral infection |
| 09/24/2013 | CA2522359C Pathotropic retroviral vector used to deliver diagnostic or therapeutic compositions |
| 09/24/2013 | CA2425669C Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
| 09/19/2013 | WO2013138668A1 Methods and compositions for the specific inhibition of mcl1 by double-stranded rna |
| 09/19/2013 | WO2013135900A1 Tricyclic nucleosides and oligomeric compounds prepared therefrom |
| 09/19/2013 | US20130245102 Novel dna templates for small rna production in mammalian cells |
| 09/19/2013 | US20130245096 COMPOSITIONS AND METHODS FOR ACTIVATING EXPRESSION BY A SPECIFIC ENDOGENOUS miRNA |
| 09/19/2013 | US20130244289 Variant humicola grisea cbh1.1 |
| 09/19/2013 | US20130244254 T1r hetero-oligomeric taste receptors |
| 09/19/2013 | US20130243816 Influenza hemagglutinin and neuraminidase variants |
| 09/19/2013 | US20130243811 Immunostimulatory oligonucleotides and uses thereof |
| 09/19/2013 | US20130243789 Multiple Gene Expression Including sORF Constructs and Methods with Polyproteins, Pro-Proteins and Proteolysis |
| 09/19/2013 | US20130243780 Antibody Selective for a Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor and Uses Thereof |
| 09/18/2013 | EP2639238A1 Tricyclic nucleosides and oligomeric compounds prepared therefrom |
| 09/18/2013 | EP2638162A2 Skin permeating and cell entering (space) peptides and methods of use thereof |
| 09/18/2013 | EP2638160A2 Nuclions and ribocapsids |
| 09/18/2013 | EP2638159A2 Compositions, kits and methods for treatment of cardiovascular, immunological, and inflammatory diseases |
| 09/18/2013 | EP2638158A1 Compositions, cells, kits and methods for autologous stem cell therapy |
| 09/18/2013 | EP2638057A1 Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom |
| 09/18/2013 | EP2638056A1 Use of 2',5'-oligoadenylate derivative compounds |
| 09/18/2013 | EP2638055A2 Consensus prostate antigens nucleic acid molecule encoding the same and vaccine and uses comprising the same |
| 09/18/2013 | CN1897969B Selective incorporation of 5-hyroxytrypophan into proteins in mammalian cells |
| 09/18/2013 | CN1694959B Non-sequence complementary antiviral oligonucleotides |
| 09/18/2013 | CN103314115A Methods and compositions for modified ethanol inducible promoter systems |
| 09/18/2013 | CN103314003A Compositions and methods for activating expression by specific endogenous miRNA |
| 09/18/2013 | CN103314002A Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same |
| 09/18/2013 | CN103314001A Novel synthesis of nucleoside 5'-triphosphates and their derivatives |
| 09/18/2013 | CN101657463B Development of dengue virus vaccine components |
| 09/18/2013 | CN101541319B Na+/K+-atpase-specific peptide inhibitors/activators of Src and Src family kinases |
| 09/18/2013 | CN101495498B Mild osteoarthritis biomarkers and uses thereof |
| 09/17/2013 | US8536415 Soybean variety XB58Y11 |
| 09/17/2013 | US8536414 Soybean variety XB09P11 |
| 09/17/2013 | US8536406 COMT1 gene fiber-specific promoter elements from poplar |
| 09/17/2013 | US8536404 Plant root-specific nematode resistance |
| 09/17/2013 | US8536322 Method for nucleic acid isolation by solid phase reversible binding of nucleic acids |
| 09/17/2013 | US8536321 Compositions, methods, and kits for the detection of Chlamydia trachomatis |
| 09/17/2013 | US8536320 Tetrahydropyran nucleic acid analogs |
| 09/17/2013 | US8536319 Compounds and methods for detecting ricin and uses thereof |
| 09/17/2013 | US8536318 Chemical RNA synthesis method |
| 09/17/2013 | US8536315 Production and purification of recombinant arylsulftase |
| 09/17/2013 | US8536149 TRPM-2 antisense therapy |
| 09/17/2013 | US8536147 Antibacterial antisense oligonucleotide and method |
| 09/17/2013 | US8535941 Lipophilic dye-based FRET assays for clostridial toxin activity |
| 09/17/2013 | US8535928 Protease and use thereof |